ArticleInternational journal of colorectal disease2025
Associations between FOXO1 expression in tissue, the pathological characteristics of colorectal cancer, and patient survival.
Article in International journal of colorectal disease, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- MRI-based radiomics for preoperative T-staging of rectal cancer: a retrospective analysis.International journal of colorectal disease · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
backgroundThe transcription factor Forkhead box O1 (FOXO1) plays key roles in many biological processes, including metabolic regulation and apoptosis. However, any role in colorectal cancer (CRC) remains to be elucidated.
methodsAn immunohistochemical tissue microarray was used to measure the expression levels of FOXO1 in cancerous tissues from 76 colorectal cancer patients and 28 paracancerous tissues. The difference in expression in the two tissues was statistically compared, and correlations were sought between FOXO1 concentrations and CRC pathological parameters and prognosis.
resultsFOXO1 positivity was significantly lower in CRC tissues than in paracancerous tissues (59.2% vs 85.7%, P = 0.011). The FOXO1 level of CRC tissues was not significantly correlated with sex, tumour size, pathological or TNM stage, Duke stage for cancer and severity, lymph node metastasis, or vascular invasion. However, low FOXO1 expression predicted poorer differentiation (P = 0.033) and higher nerve invasion (P < 0.001). Kaplan-Meier survival analysis revealed that the 5-year survival rate was significantly higher in patients expressing FOXO1 (75.6%; 34/45) than not (54.8%; 17/31). In the multivariable Cox proportional hazards model analysis, high FOXO1 expression remained independently associated with better overall survival (HR = 0.46, 95% CI 0.25-0.86, P = 0.016).
conclusionFOXO1 expression is significantly correlated with the pathological features of CRC and patient prognosis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.